Fig. 7
HGFK1 inhibits sorafenib-induced autophagy via inhibiting NF-κB signaling pahtway. a Ketr-3 and ACHN cells were treated with sorafenib and/or rHGFK1, Bay 11–7082, then analyzed by Western-Blotting. b Ketr-3 cells were treated with sorafenib and/or rHGFK1, then analyzed by mRFP-GFP-LC3 puncta formation assay. c Ketr-3 cells were treated with sorafenib and/or Bay 11–7082, then analyzed the cell apoptosis by flow cytometer. Significant differences are denoted by *** for p < 0.001